Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:04AM EST. Market open.
| Previous close | 26.82 |
| Open | 26.53 |
| Bid | 27.11 x 900 |
| Ask | 27.44 x 900 |
| Day's range | 26.46 - 27.61 |
| 52-week range | 15.58 - 48.40 |
| Volume | |
| Avg. volume | 171,955 |
| Market cap | 727.568M |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.04 |
| Earnings date | 28 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 49.63 |
- Business Wire
Castle Biosciences to Release Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on Tuesday, Feb. 28, 2023
FRIENDSWOOD, Texas, February 07, 2023--Castle will release its financial results for the fourth quarter and year ended Dec. 31, 2022, after the close of market on Tuesday, Feb. 28, 2023.
- Business Wire
Castle Biosciences Earns a Top Workplaces USA Award for the Second Consecutive Year
FRIENDSWOOD, Texas, February 01, 2023--Castle announced that it has received a 2023 Top Workplaces USA award from Energage.
- Business Wire
Castle Biosciences’ Medical Director to Present at the Precision Medicine World Conference 2023
FRIENDSWOOD, Texas, January 23, 2023--Castle's medical director, Matthew Goldberg, M.D., F.A.A.D., will present at the Precision Medicine World Conference (PMWC®) 2023 on Jan. 25.
© 2023 Yahoo. All rights reserved.
